Effect of Posttranslational Modifications and Subclass on IgG Activity: from Immunity to Immunotherapy

Overview

Journal Nat Immunol

Date 2023 Jul 6

PMID 37414906

Authors

Falk Nimmerjahn

Gestur Vidarsson

Mark S Cragg

Affiliations

Soon will be listed here.

Abstract

Humoral immune responses are characterized by complex mixtures of polyclonal antibody species varying in their isotype, target epitope specificity and affinity. Posttranslational modifications occurring during antibody production in both the antibody variable and constant domain create further complexity and can modulate antigen specificity and antibody Fc-dependent effector functions, respectively. Finally, modifications of the antibody backbone after secretion may further impact antibody activity. An in-depth understanding of how these posttranslational modifications impact antibody function, especially in the context of individual antibody isotypes and subclasses, is only starting to emerge. Indeed, only a minute proportion of this natural variability in the humoral immune response is currently reflected in therapeutic antibody preparations. In this Review, we summarize recent insights into how IgG subclass and posttranslational modifications impact IgG activity and discuss how these insights may be used to optimize therapeutic antibody development.

Citing Articles

IgA displays site- and subclass-specific glycoform differences despite equal glycoenzyme expression.

Falck D, Sokolova M, Koeleman C, Irumva V, Kirchner P, Schulz S Cell Commun Signal. 2025; 23(1):92.

PMID: 39962487 PMC: 11834270. DOI: 10.1186/s12964-025-02088-0.

Wurmb Extract Recovered Compromised Immune Status Induced by Forced Swimming in a Mouse Model.

Kim G, Yoo S, Song J, Lim K, Lim E, Yoo J J Microbiol Biotechnol. 2025; 35:e2411006.

PMID: 39849928 PMC: 11813364. DOI: 10.4014/jmb.2411.11006.

Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria.

Lopez-Perez M, Seidu Z, Larsen M, Wang W, Nouta J, Wuhrer M Nat Commun. 2025; 16(1):237.

PMID: 39747065 PMC: 11696684. DOI: 10.1038/s41467-024-55543-w.

Unveiling the link: anti-protein disulfide isomerase A3 autoantibody expression and polycystic ovary syndrome risk in euthyroid autoimmune thyroiditis women.

Chen Z, Zhang C, Meng C, Hu Y, Niu Y, Gao B J Ovarian Res. 2024; 17(1):247.

PMID: 39702372 PMC: 11656784. DOI: 10.1186/s13048-024-01569-z.

The role of placenta Hofbauer cells during pregnancy and pregnancy complications.

Yang S, Hwang H, Kang Y Obstet Gynecol Sci. 2024; 68(1):9-17.

PMID: 39662509 PMC: 11788695. DOI: 10.5468/ogs.24247.

References

Ding L, Chen X, Cheng H, Zhang T, Li Z . Advances in IgA glycosylation and its correlation with diseases. Front Chem. 2022; 10:974854. PMC: 9552352. DOI: 10.3389/fchem.2022.974854. View

Shade K, Conroy M, Anthony R . IgE Glycosylation in Health and Disease. Curr Top Microbiol Immunol. 2019; 423:77-93. PMC: 6750212. DOI: 10.1007/82_2019_151. View

Sun Y, Li X, Wang T, Li W . Core Fucosylation Regulates the Function of Pre-BCR, BCR and IgG in Humoral Immunity. Front Immunol. 2022; 13:844427. PMC: 8990897. DOI: 10.3389/fimmu.2022.844427. View

Pincetic A, Bournazos S, DiLillo D, Maamary J, Wang T, Dahan R . Type I and type II Fc receptors regulate innate and adaptive immunity. Nat Immunol. 2014; 15(8):707-16. PMC: 7430760. DOI: 10.1038/ni.2939. View

Vidarsson G, Dekkers G, Rispens T . IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014; 5:520. PMC: 4202688. DOI: 10.3389/fimmu.2014.00520. View

Challa D, Velmurugan R, Ober R, Ward E . FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions. Curr Top Microbiol Immunol. 2014; 382:249-72. DOI: 10.1007/978-3-319-07911-0_12. View

Nimmerjahn F, Ravetch J . Four keys to unlock IgG. J Exp Med. 2021; 218(3). PMC: 7888349. DOI: 10.1084/jem.20201753. View

Black C . A brief history of the discovery of the immunoglobulins and the origin of the modern immunoglobulin nomenclature. Immunol Cell Biol. 1997; 75(1):65-8. DOI: 10.1038/icb.1997.10. View

Lefranc G, Chaabani H, van Loghem E, Lefranc M, De Lange G, Helal A . Simultaneous absence of the human IgG1, IgG2, IgG4 and IgA1 subclasses: immunological and immunogenetical considerations. Eur J Immunol. 1983; 13(3):240-4. DOI: 10.1002/eji.1830130312. View

10.

Pan Q, Hammarstrom L . Molecular basis of IgG subclass deficiency. Immunol Rev. 2001; 178:99-110. DOI: 10.1034/j.1600-065x.2000.17815.x. View

11.

Jefferis R, Lefranc M . Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs. 2010; 1(4):332-8. PMC: 2726606. DOI: 10.4161/mabs.1.4.9122. View

12.

de Taeye S, Bentlage A, Mebius M, Meesters J, Lissenberg-Thunnissen S, Falck D . FcγR Binding and ADCC Activity of Human IgG Allotypes. Front Immunol. 2020; 11:740. PMC: 7218058. DOI: 10.3389/fimmu.2020.00740. View

13.

Labrijn A, Ortiz Buijsse A, van den Bremer E, Verwilligen A, Bleeker W, Thorpe S . Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo. Nat Biotechnol. 2009; 27(8):767-71. DOI: 10.1038/nbt.1553. View

14.

Orr C, Fisher H, Yu X, Chan C, Gao Y, Duriez P . Hinge disulfides in human IgG2 CD40 antibodies modulate receptor signaling by regulation of conformation and flexibility. Sci Immunol. 2022; 7(73):eabm3723. DOI: 10.1126/sciimmunol.abm3723. View

15.

Gordan S, Biburger M, Nimmerjahn F . bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression. Immunol Rev. 2015; 268(1):52-65. DOI: 10.1111/imr.12347. View

16.

Kerntke C, Nimmerjahn F, Biburger M . There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood Leukocytes. Front Immunol. 2020; 11:118. PMC: 7013094. DOI: 10.3389/fimmu.2020.00118. View

17.

Vorsatz C, Friedrich N, Nimmerjahn F, Biburger M . There Is Strength in Numbers: Quantitation of Fc Gamma Receptors on Murine Tissue-Resident Macrophages. Int J Mol Sci. 2021; 22(22). PMC: 8620503. DOI: 10.3390/ijms222212172. View

18.

Kaplon H, Chenoweth A, Crescioli S, Reichert J . Antibodies to watch in 2022. MAbs. 2022; 14(1):2014296. PMC: 8765076. DOI: 10.1080/19420862.2021.2014296. View

19.

Raybould M, Marks C, Krawczyk K, Taddese B, Nowak J, Lewis A . Five computational developability guidelines for therapeutic antibody profiling. Proc Natl Acad Sci U S A. 2019; 116(10):4025-4030. PMC: 6410772. DOI: 10.1073/pnas.1810576116. View

20.

Diebolder C, Beurskens F, de Jong R, Koning R, Strumane K, Lindorfer M . Complement is activated by IgG hexamers assembled at the cell surface. Science. 2014; 343(6176):1260-3. PMC: 4250092. DOI: 10.1126/science.1248943. View